Acyclovir
- Product NDC
- 70518-2455
- 11-digit product format
- 705182455
- Labeler code
- 70518
- Product ID
- 70518-2455_4a291680-febd-5eac-e063-6394a90ab919
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA203834
- Marketing category
- ANDA
- Marketing start
- 2019-11-25
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 70518-2455 | 70518-2455-0 | D | Discontinued by firm | 2026-08-10 | |
| excluded package | package | 70518-2455 | 70518-2455-1 | D | Discontinued by firm | 2026-08-10 | |
| excluded package | package | 70518-2455 | 70518-2455-4 | D | Discontinued by firm | 2026-08-10 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 70518-2455-4 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 70518-2455-0 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 70518-2455-4 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 70518-2455-0 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 70518-2455-0 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 70518-2455-0 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 70518-2455-0 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 70518-2455-0 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 70518-2455-1 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 70518-2455-0 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 70518-2455-1 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 70518-2455-0 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 70518-2455-1 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 70518-2455-0 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 70518-2455-1 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 70518-2455-0 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 70518-2455-1 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 70518-2455-0 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 70518-2455-1 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 70518-2455-0 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203834-001 | ACYCLOVIR | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | |
| A203834-002 | ACYCLOVIR | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203834-001 | AB |
| A203834-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2013-10-29 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A203834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2013-10-29 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A203834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | RS | 2013-10-29 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203834-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203834-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203834-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203834-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A203834-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203834-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203834-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203834-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203834-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203834-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203834-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203834-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203834-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203834-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203834-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203834-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203834-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203834-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A203834-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A203834-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203834-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203834-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203834-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203834-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203834-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203834-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A203834-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A203834-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203834-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203834-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A203834-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A203834-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A203834-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A203834-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A203834-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A203834-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A203834-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A203834-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A203834-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A203834-002 | AB | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acyclovir
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACYCLOVIR | 400 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| X4HES1O11F | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 197311 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6d0e492e-5359-49e8-812d-8c8e2e5d42f8 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 33190c02-82e1-0a4d-d716-9ccd23588463 | Product name | 5 | 20250225 |
| c367d1da-5a72-8966-6d11-1eb9a73ae758 | Product name | 3 | 20231115 |
| 5518bf13-db2f-2e9c-3679-e70ecf03752c | Product name | 9 | 20210614 |
| 27897900-0e40-497b-97e1-88057e68fe6c | Product name | 4 | 20200710 |
| ca834e59-e669-229c-9288-0ccb76dc373e | Product name | 9 | 20200220 |
| d7f95c49-d3e1-4bbc-a389-e9cd73f59a28 | Product name | 1 | 20190702 |
| fb15b394-3715-4c87-a447-421489aa8739 | Product name | 3 | 20170727 |
| 7bdc4804-3832-c0df-e519-72b6d47c9792 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-2455-0 | Acyclovir | 30 in 1 BLISTER PACK | TABLET | 30 | 15 | |
| 70518-2455-1 | Acyclovir | 15 in 1 BOTTLE, PLASTIC | TABLET | 15 | 15 | |
| 70518-2455-2 | Acyclovir | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 15 | |
| 70518-2455-3 | Acyclovir | 21 in 1 BOTTLE, PLASTIC | TABLET | 21 | 15 | |
| 70518-2455-4 | Acyclovir | 50 in 1 BOTTLE, PLASTIC | TABLET | 50 | 15 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70518-2455-1 | EA - Each | 70518-2455 | 29b478eb-6a37-414a-a3da-4aa3708ef4f5 | 1 | 2023-01-09 |
| 70518-2455-2 | EA - Each | 70518-2455 | 888ff41b-37dc-45c7-9ed0-0fbe6b6be70b | 1 | 2026-01-08 |
| 70518-2455-3 | EA - Each | 70518-2455 | c17c0354-d3fa-49ae-aac7-3135cd67e3ae | 1 | 2023-01-09 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-2455 | ACYCLOVIR TABLET [REMEDYREPACK INC.] | 13 | Current NDC, Legacy NDC, 5 package rows | 20250316_6d0e492e-5359-49e8-812d-8c8e2e5d42f8.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 6d0e492e-5359-49e8-812d-8c8e2e5d42f8 | 2026-07-24 | Warnings, Adverse reactions | 203834 ANDA203834 70518-2455 |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 736679be-469e-4bdb-8e15-b10751c3dd60 | 2026-07-24 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 38547daa-7d2f-4a7b-84d3-6e164984f958 | 2026-07-17 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | St. Mary's Medical Park Pharmacy | 1493e22d-455d-b613-e063-6294a90afede | 2026-06-04 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | dbdb7903-0991-413d-b1ad-ab0f1ae2d8f4 | 2026-06-04 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | db0a0ce5-dc39-4bd3-8b97-21ce9c9999f0 | 2026-05-27 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 0e78d5e8-ae2d-4e84-b8c2-6765b1299c12 | 2026-05-21 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | e8a0f9f8-294f-4dd6-bd55-10a6253f1aa8 | 2026-04-29 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | Major Pharmaceuticals | 46150f19-ce5d-42a0-80a7-f96fda2b9879 | 2026-02-18 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | Preferred Pharmaceuticals, Inc. | b6d69697-12bb-4548-a6c3-2463cbf54f8f | 2026-02-11 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | Camber Pharmaceuticals, Inc. | 0910335b-6796-459f-b97e-d7ef5439a060 | 2026-02-02 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | Northwind Health Company, LLC | 5dcfd21c-43f0-469c-be70-a4e74e6ccf88 | 2026-01-01 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | Northwind Health Company, LLC | f6f56143-ea74-af87-e053-6394a90ae346 | 2026-01-01 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | Advanced Rx Pharmacy of Tennessee, LLC | f4c5779d-e4bf-4f2b-e053-2995a90a9187 | 2024-12-31 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | 638803d2-a172-486d-e053-2991aa0ab074 | 2024-07-16 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals, Inc. | 5176c7f9-9076-4797-e054-00144ff8d46c | 2024-07-08 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | 83e82707-85b6-2fea-e053-2991aa0a99ef | 2024-06-14 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | e4f91376-9e18-41a4-aa5e-adcea0c625d9 | 2023-12-05 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | PharmPak, Inc. | d824fc07-9f03-4cb2-9bf8-ff7cc2955255 | 2022-10-09 | Warnings, Adverse reactions | 203834 ANDA203834 |
| Acyclovir | ACYCLOVIR | PharmPak, Inc. | 8fb01f23-e2bd-6850-e053-2995a90a7cc5 | 2022-10-09 | Warnings, Adverse reactions | 203834 ANDA203834 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197311 | acyclovir 400 MG Oral Tablet | PSN | 6d0e492e-5359-49e8-812d-8c8e2e5d42f8 | 15 |
| 197311 | acyclovir 400 MG Oral Tablet | SCD | 6d0e492e-5359-49e8-812d-8c8e2e5d42f8 | 15 |
| 197311 | acycycloguanosine 400 MG Oral Tablet | SY | 6d0e492e-5359-49e8-812d-8c8e2e5d42f8 | 15 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-2455-0 | 70518245500 | 30 TABLET in 1 BLISTER PACK (70518-2455-0) | 30 tablet | 2019-11-25 | 0000-00-00 | No | No | Current |
| 70518-2455-1 | 70518245501 | 15 TABLET in 1 BOTTLE, PLASTIC (70518-2455-1) | 15 tablet | 2020-09-08 | 0000-00-00 | No | No | Current |
| 70518-2455-2 | 70518245502 | 30 TABLET in 1 BOTTLE, PLASTIC (70518-2455-2) | 30 tablet | 2020-10-23 | 0000-00-00 | No | No | Current |
| 70518-2455-3 | 70518245503 | 21 TABLET in 1 BOTTLE, PLASTIC (70518-2455-3) | 21 tablet | 2021-08-25 | 0000-00-00 | No | No | Current |
| 70518-2455-4 | 70518245504 | 50 in 1 BOTTLE, PLASTIC | Historical |